Literature DB >> 30345613

Developmental delay and failure to thrive associated with a loss-of-function variant in WHSC1 (NSD2).

Nicole J Boczek1, Carrie A Lahner1, Thuy-Mi Nguyen1,2, Matthew J Ferber1,2, Linda Hasadsri1, Erik C Thorland1,2, Zhiyv Niu1,2, Ralitza H Gavrilova2,3.   

Abstract

Wolf-Hirschhorn syndrome (WHS) is a microdeletion syndrome characterized by distinctive facial features consisting of "Greek warrior helmet" appearance, prenatal and postnatal growth deficiency, developmental disability, and seizures. This disorder is caused by heterozygous deletions on chromosome 4p16.3 often identified by cytogenetic techniques. Many groups have attempted to identify the critical region within this deletion to establish which genes are responsible for WHS. Herein, clinical whole exome sequencing (WES) was performed on a child with developmental delays, mild facial dysmorphisms, short stature, failure to thrive, and microcephaly, and revealed a de novo frameshift variant, c.1676_1679del (p.Arg559Tfs*38), in WHSC1 (NSD2). While WHSC1 falls within the WHS critical region, individuals with only disruption of this gene have only recently been described in the literature. Loss-of-function de novo variations in WHSC1 were identified in large developmental delay, autism, diagnostic, and congenital cardiac cohorts, as well as recent case reports, suggesting that de novo loss-of-function WHSC1 variants may be related to disease. These findings, along with our patient suggest that loss-of-function variation in WHSC1 may lead to a mild form of Wolf-Hirschhorn syndrome, and also may suggest that the developmental delays, facial dysmorphisms, and short stature seen in WHS may be due to disruption of WHSC1 gene.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  zzm321990NSD2; zzm321990WHSC1; developmental delay; short stature; whole exome sequencing; wolf-Hirschhorn syndrome

Mesh:

Substances:

Year:  2018        PMID: 30345613     DOI: 10.1002/ajmg.a.40498

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  10 in total

1.  Transcriptome-directed analysis for Mendelian disease diagnosis overcomes limitations of conventional genomic testing.

Authors:  David R Murdock; Hongzheng Dai; Lindsay C Burrage; Jill A Rosenfeld; Shamika Ketkar; Michaela F Müller; Vicente A Yépez; Julien Gagneur; Pengfei Liu; Shan Chen; Mahim Jain; Gladys Zapata; Carlos A Bacino; Hsiao-Tuan Chao; Paolo Moretti; William J Craigen; Neil A Hanchard; Brendan Lee
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

2.  The genomic response of human granulosa cells (KGN) to melatonin and specific agonists/antagonists to the melatonin receptors.

Authors:  Asma Arjoune; Marc-André Sirard
Journal:  Sci Rep       Date:  2022-10-20       Impact factor: 4.996

Review 3.  Histone lysine methyltransferases in biology and disease.

Authors:  Dylan Husmann; Or Gozani
Journal:  Nat Struct Mol Biol       Date:  2019-10-03       Impact factor: 15.369

4.  De novo loss-of-function variants in NSD2 (WHSC1) associate with a subset of Wolf-Hirschhorn syndrome.

Authors:  Elizabeth S Barrie; Maria P Alfaro; Ruthann B Pfau; Melanie J Goff; Kim L McBride; Kandamurugu Manickam; Erik J Zmuda
Journal:  Cold Spring Harb Mol Case Stud       Date:  2019-08-01

5.  The NSD2/WHSC1/MMSET methyltransferase prevents cellular senescence-associated epigenomic remodeling.

Authors:  Hiroshi Tanaka; Tomoka Igata; Kan Etoh; Tomoaki Koga; Shin-Ichiro Takebayashi; Mitsuyoshi Nakao
Journal:  Aging Cell       Date:  2020-06-22       Impact factor: 9.304

6.  The first familial NSD2 cases with a novel variant in a Chinese father and daughter with atypical WHS facial features and a 7.5-year follow-up of growth hormone therapy.

Authors:  Xuyun Hu; Di Wu; Yuchuan Li; Liya Wei; Xiaoqiao Li; Miao Qin; Hongdou Li; Mengting Li; Shaoke Chen; Chunxiu Gong; Yiping Shen
Journal:  BMC Med Genomics       Date:  2020-12-04       Impact factor: 3.063

7.  Alternatively Splicing Interactomes Identify Novel Isoform-Specific Partners for NSD2.

Authors:  Weidi Wang; Yucan Chen; Jingjing Zhao; Liang Chen; Weichen Song; Li Li; Guan Ning Lin
Journal:  Front Cell Dev Biol       Date:  2021-02-25

Review 8.  From Wolf-Hirschhorn syndrome to NSD2 haploinsufficiency: a shifting paradigm through the description of a new case and a review of the literature.

Authors:  Luisa Cortellazzo Wiel; Irene Bruno; Egidio Barbi; Fabio Sirchia
Journal:  Ital J Pediatr       Date:  2022-05-12       Impact factor: 3.288

9.  De novo truncating variant in NSD2gene leading to atypical Wolf-Hirschhorn syndrome phenotype.

Authors:  Yanrui Jiang; Huizhen Sun; Qingmin Lin; Zengge Wang; Guanghai Wang; Jian Wang; Fan Jiang; Ruen Yao
Journal:  BMC Med Genet       Date:  2019-08-05       Impact factor: 2.103

10.  Loss-of-function and missense variants in NSD2 cause decreased methylation activity and are associated with a distinct developmental phenotype.

Authors:  Paolo Zanoni; Katharina Steindl; Deepanwita Sengupta; Or Gozani; Anita Rauch; Pascal Joset; Angela Bahr; Heinrich Sticht; Mariarosaria Lang-Muritano; Conny M A van Ravenswaaij-Arts; Marwan Shinawi; Marisa Andrews; Tania Attie-Bitach; Isabelle Maystadt; Newell Belnap; Valerie Benoit; Geoffroy Delplancq; Bert B A de Vries; Sarah Grotto; Didier Lacombe; Austin Larson; Jeroen Mourmans; Katrin Õunap; Giulia Petrilli; Rolph Pfundt; Keri Ramsey; Lot Snijders Blok; Vassilis Tsatsaris; Antonio Vitobello; Laurence Faivre; Patricia G Wheeler; Marijke R Wevers; Monica Wojcik; Markus Zweier
Journal:  Genet Med       Date:  2021-05-03       Impact factor: 8.822

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.